About us

Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

Calliditas’ lead product, developed under the name Nefecon, has been granted accelerated approval by the FDA under the trade name TARPEYO® and conditional marketing authorization by the European Commission under the trade name KINPEYGO®. 

TARPEYO and KINPEYGO® are the first treatments approved for IgA nephropathy by the FDA and EMA, respectively.

Calliditas also has a pipeline in orphan-focused indications. Calliditas is conducting a Phase 2b/3 clinical trial in primary biliary cholangitis and a Phase 2 proof-of-concept trial in head and neck cancer with its NOX inhibitor product candidate, setanaxib.

Calliditas’ common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT).

Position summary

The Director, National Accounts leads a National Accounts team focused on creating profitable access and ensuring appropriate placement of Calliditas’ medicines in formularies, treatment algorithms, pharmacy policies and medical policies across payer customers which may include, but not limited to, national payers, PBMs, health plans, Medicare plans and Medicaid. When contracting is necessary to achieve profitable access, the Director works with the National Accounts team to lead the contracting process, monitor contract performance, and identify opportunities for adjustment.

The Director will be responsible for leading the National Accounts team to engage in frequent and compliant discussions with key decision makers, to manage, assess and, if appropriate, impact change of existing policies. This individual must ensure the National Accounts team maintains up to date knowledge of the Company’s and competition's products, strategies, account priorities and the broader healthcare landscape.

Success in this role will require close interaction, communication and collaborate with other market access functional areas, to shape strategy, maximize opportunity and mitigate patient access and profitability risk.

This position reports to the Vice President of Market Access. Travel across the US to see customers and meet with HQ-based teams is required. 

Key tasks and responsibilities 

Lead the National Accounts team to

• Develop and execute on customer specific strategic account plans.
• Execute on customer specific strategies and tactics to support appropriate formulary placement and reimbursement across payer customers that lead to profitable access.
• Work with Patient Support and FRM to assure accurate coverage determinations and resolve customer issues.
• Establish credible business relationships with key accounts and in other organizations that influence those accounts (e.g., provider groups, hospital systems, regional payers).
• Assist in training the field on payer knowledge and formulary/processes for reimbursement.
• Routinely review data (sales, trends, comparison etc.) to identify pull-through opportunities, and work with sales leadership team to execute on aligned pull-through plans.
• Represent the Market Access organization, with professionalism and integrity, at national payer organizations meetings and internally with various departmental and leadership team.
• Negotiate cost-effective, profitable contracts that allow access to our products by providers and their patients, within established product pricing policy and GTN guidance.

Education and experience requirements

• Bachelor's degree required; Master's/advanced degree preferred.
• Minimum ten years pharmaceutical/biotech experience in NAM, KAM, or sales management with at least five years of experience in a market access leadership role leading account team.
• Deep understanding and knowledge of the managed market dynamics, payer/PBM economics, and the key issues/shifts changing the US healthcare landscape.
• Proficiency in VA/DOD and Medicaid preferred.
• Demonstrated ability to work collaboratively with and influence senior leaders and peers. Good communication skills, both verbal and written.
• Established relationships with Pharmacy Directors, Medical Directors, and other key personnel at key payer accounts.
• Demonstrated knowledge of payer decision-making for formulary processes, coverage, coding, billing, pathway development and patient access to medicines.
• Therapeutic experience in rare or orphan diseases.
• Ability to assist in the development of managed care and account.
• Ability to be flexible and multitask among numerous demands.
• Demonstrated ability to develop, communicate, and implement successful strategic initiatives.
• Strong business acumen. Experience in negotiating contracts and agreements. Experience with Value Based Contracting in an orphan drug or specialty space desired.

Reasons to join the Calliditas Team

• Be a part of a global leader in IgA-Nephropathy and a rapidly growing commercial-stage pharmaceutical company within specialty products with strong growth ambitions and a strong pipeline
• Fast paced small company environment
• A unique corporate culture
• Dedicated, experienced and highly skilled colleagues
• Participate on bonus and benefit programs

Welcome to join the Calliditas Team!

Calliditas provides equal employment opportunities to all employees and job applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, protected veteran status, pregnancy or any other legally protected status. For a copy of the Affirmative Action Plan and EEO Statement, contact [email protected].

Calliditas is an E-Verify employer.

COVID-19 Vaccination is a requirement, subject to any religious or medical accommodation.